Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 116, 105358
Abstract
No abstract availableKeywords
Funding Information
- ICMR
This publication has 36 references indexed in Scilit:
- Evaluation of Mammary Cancer in 7,12-Dimethylbenz(a)anthracene-Induced Wister Rats by Asymmetrical Temperature Distribution Analysis Using Thermography: A Comparison with Serum CEA Levels and HistopathologyJournal of Biomedicine and Biotechnology, 2012
- Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitorsProceedings of the National Academy of Sciences, 2012
- Signal Transduction by Vascular Endothelial Growth Factor ReceptorsCold Spring Harbor Perspectives in Medicine, 2012
- A Novel Function of p38-Regulated/Activated Kinase in Endothelial Cell Migration and Tumor AngiogenesisMolecular and Cellular Biology, 2012
- Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivativesEuropean Journal of Medicinal Chemistry, 2011
- Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid TumorsClinical Cancer Research, 2010
- Angiogenesis: an organizing principle for drug discovery?Nature Reviews Drug Discovery, 2007
- The Role of VEGF and EGFR Inhibition: Implications for Combining Anti–VEGF and Anti–EGFR AgentsMolecular Cancer Research, 2007
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006
- Discovery of 5-[5-Fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic Acid (2-Diethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine KinaseJournal of Medicinal Chemistry, 2003